PubRank

A Bensussan

Author PubWeight™ 109.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest 1985 2.77
2 Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. J Immunol 1985 2.37
3 CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996 2.30
4 Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A 1996 1.80
5 Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000 1.67
6 Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. Nature 1988 1.53
7 Delineation of an immunoregulatory amplifier population recognizing autologous Ia molecules. Analysis with human T cell clones. J Exp Med 1984 1.49
8 Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol 2001 1.42
9 Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 1992 1.40
10 Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol 2001 1.38
11 T lymphocytes bearing the gamma delta T cell receptor in patients with acute Plasmodium falciparum malaria. J Infect Dis 1990 1.32
12 Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 1999 1.32
13 Clonotypic surface structure on human T lymphocytes: functional and biochemical analysis of the antigen receptor complex. Immunol Rev 1984 1.24
14 Functional isotypes are not encoded by the constant region genes of the beta subunit of the T cell receptor for antigen/major histocompatibility complex. J Exp Med 1984 1.24
15 T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane. J Exp Med 1998 1.22
16 Regulation of transcription of the human T cell antigen receptor delta chain gene. A T lineage-specific enhancer element is located in the J delta 3-C delta intron. J Exp Med 1990 1.22
17 The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur Cytokine Netw 1997 1.20
18 ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 2012 1.19
19 A human T lymphoblastic cell line lacks lamins A and C. EMBO J 1987 1.18
20 Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum. Clin Exp Immunol 1994 1.14
21 A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med 1993 1.11
22 T3-Ti receptor triggering of T8+ suppressor T cells leads to unresponsiveness to interleukin-2. Nature 1984 1.09
23 Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 1998 1.09
24 Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantation. J Clin Invest 1988 1.06
25 CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol 1996 1.04
26 Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res 1999 1.04
27 Interferon: a cytotoxic T lymphocyte differentiation signal. Eur J Immunol 1986 1.04
28 Human decidual NK cells: unique phenotype and functional properties -- a review. Placenta 2006 1.03
29 Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood 1998 1.02
30 The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones. J Immunol 1985 1.02
31 c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes. Oncogene 2009 1.01
32 Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb. Int Immunol 1995 1.00
33 Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997 1.00
34 Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur J Immunol 2000 0.99
35 Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 1999 0.98
36 Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity. J Immunol 1987 0.97
37 CD100 is a leukocyte semaphorin. Cell Mol Life Sci 1998 0.97
38 IL-10 producing regulatory B cells in mice and humans: state of the art. Curr Mol Med 2012 0.96
39 The human semaphorin-like leukocyte cell surface molecule CD100 associates with a serine kinase activity. J Biol Chem 1997 0.95
40 What is a T-cell clone? Effect of rIFN on T-cell clone function and T-cell receptor gene rearrangement. Hum Immunol 1986 0.95
41 Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas. Oncogene 2006 0.95
42 Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones. Proc Natl Acad Sci U S A 1985 0.94
43 Lymphocytes subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood. Tissue Antigens 1996 0.94
44 Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. J Invest Dermatol 2000 0.94
45 The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells. Eur J Immunol 1992 0.93
46 CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs. J Clin Invest 1998 0.93
47 Prominent expansion of circulating lymphocytes bearing gamma T-cell receptors, with preferential expression of variable gamma genes after allogeneic bone marrow transplantation. Blood 1988 0.93
48 Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas. Br J Dermatol 2014 0.92
49 The human T-cell receptor. J Clin Immunol 1985 0.92
50 CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. Blood 2001 0.90
51 Erythrodermic cutaneous T-cell lymphoma with disseminated pustulosis. Production of high levels of interleukin-8 by tumour cells. Br J Dermatol 2001 0.90
52 Recombinant interferon alpha can induce rearrangement of T-cell antigen receptor alpha-chain genes and maturation to cytotoxicity in T-lymphocyte clones in vitro. Proc Natl Acad Sci U S A 1986 0.88
53 Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol 2000 0.88
54 Regulation of the human allogenic proliferative response in vitro. II. Production of soluble suppressor factors by suppressor T cells and evidence in favor of "acceptor" cells for suppression among unprimed lymphocytes. Immunogenetics 1981 0.88
55 Use of a variable alpha region to create a functional T-cell receptor delta chain. Proc Natl Acad Sci U S A 1988 0.87
56 Suppression of lymphocyte reactivity by blood transfusions in uremic patients. I. Proliferative responses. Transplantation 1983 0.87
57 Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. Involvement of a metalloprotease in the specific hydrolytic release of the soluble isoform. J Immunol 1995 0.87
58 Suppression of the human allogenetic response in vitro with primed lymphocytes and suppressive supernates. J Exp Med 1980 0.86
59 Proliferation of resting lymphocytes is induced by triggering T cells through an epitope common to the three CD18/CD11 leukocyte adhesion molecules. Cell Immunol 1991 0.86
60 BCL2 and JUNB abnormalities in primary cutaneous lymphomas. Br J Dermatol 2004 0.86
61 Do primary cutaneous non-T non-B CD4+CD56+ lymphomas belong to the myelo-monocytic lineage? J Invest Dermatol 1998 0.86
62 Respiratory burst in human B lymphocytes. Triggering of surface Ig receptors induces modulation of chemiluminescence signal. J Immunol 1991 0.85
63 TCR gamma delta bearing T lymphocytes infiltrating human primary cutaneous melanomas. J Invest Dermatol 1992 0.85
64 Retracted Clonal analysis of B cell growth and differentiation activities induced from T lymphocytes upon triggering of T3-Ti and T11 pathways. J Immunol 1985 0.85
65 Switch in the protein tyrosine phosphatase associated with human CD100 semaphorin at terminal B-cell differentiation stage. Blood 2000 0.85
66 Expression of the T cell gamma gene by a functionally defined human T cell clone. Characterization at DNA, RNA, and cell membrane level. Scand J Immunol 1988 0.83
67 Allogeneic T cell activation triggering by MHC class I antigens. J Immunol 1988 0.83
68 Production and characterization of antibody probes directed at constant regions of the alpha and beta subunit of the human T cell receptor. Eur J Immunol 1985 0.83
69 Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules. Tissue Antigens 2000 0.83
70 Natural killer cells are the unique lymphocyte cell subset which do not express HLA-G. Nat Immun 1995 0.83
71 In vitro differentiation from a pluripotent human CD4+CD8+ thymic cloned cell into four phenotypically distinct subsets. J Immunol 1990 0.83
72 Correlation between T cell receptor gamma delta isotypic forms and cytotoxic activity: analysis with human T cell clones and lines. Cell Immunol 1990 0.83
73 Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1999 0.81
74 Infiltrating lymphocytes in benign and malignant naevomelanocytic lesions. Nouv Rev Fr Hematol 1990 0.81
75 Increased expression of a novel early activation surface membrane receptor in cutaneous T cell lymphoma cells. J Invest Dermatol 2001 0.81
76 Functional characterization of neurotensin receptors in human cutaneous T cell lymphoma malignant lymphocytes. J Invest Dermatol 2001 0.80
77 Identification of a novel 110-kilodalton structure expressed on a subset of T cell receptor-gamma delta-bearing cloned lymphocytes. J Immunol 1990 0.80
78 Functional role of PECAM-1/CD31 molecule expressed on human cord blood progenitors. Leukemia 1996 0.80
79 Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis. Clin Exp Allergy 2011 0.80
80 Nucleotide sequence of a cDNA corresponding to a new human variable region of a functionally rearranged T cell receptor gamma chain. Nucleic Acids Res 1987 0.80
81 Study of the CD3-associated T-cell receptors reveals further differences between T-cell acute lymphoblastic lymphoma and leukemia. Blood 1990 0.80
82 Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis. Blood 2013 0.79
83 Allospecific proliferative human T-cell clones acquire the cytotoxic effector function after three months in culture, in IL-2 conditioned medium. Hum Immunol 1986 0.79
84 CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation. Tissue Antigens 1997 0.79
85 CD101 expression by Langerhans cell histiocytosis cells. Histopathology 2000 0.78
86 Potential antileukemic effect of gamma delta T cells in acute lymphoblastic leukemia. Leukemia 1995 0.78
87 Determination of soluble HLA-G and HLA-A, -B, and -C molecules in pregnancy. Transplant Proc 1999 0.78
88 Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy. Br J Dermatol 2003 0.78
89 Probable role of suppressor cells and factors in kidney graft survival. Transplant Proc 1982 0.78
90 Allosensitized T cells produce soluble factors susceptible to suppress allogeneic proliferation but not to interfere on cell mediated cytotoxicity. Medicina (B Aires) 1981 0.78
91 Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas. Leuk Lymphoma 2002 0.78
92 [Phorbol diester induces phenotypic and functional changes in human T-lymphocyte clones]. C R Acad Sci III 1985 0.78
93 Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sézary syndrome. Br J Dermatol 2009 0.78
94 Study of cord blood natural killer cell suppressor activity. Eur J Haematol 2001 0.78
95 Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. Ann N Y Acad Sci 2001 0.77
96 Blood transfusions suppress lymphocyte reactivity in uremic patients. II. Evidence for soluble suppressor factors. Transplantation 1983 0.77
97 Rearranging sequence located in the intron of the human T cell receptor gamma chain gene constant region. Eur J Immunol 1989 0.77
98 CD antigens 2001. J Leukoc Biol 2001 0.77
99 Tubal versus uterine placentation: similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens 2000 0.77
100 Functional inhibitory receptors expressed by a cutaneous T cell lymphoma-specific cytolytic clonal T cell population. J Invest Dermatol 2000 0.77
101 Interferon-gamma rescues HLA class Ia cell surface expression in term villous trophoblast cells by inducing synthesis of TAP proteins. Eur J Immunol 1997 0.77
102 Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways. Eur J Immunol 1991 0.77
103 Functional characterization of an IL-7-dependent CD4(+)CD8alphaalpha(+) Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma. Blood 2000 0.77
104 Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication. J Virol 1992 0.77
105 A monoclonal antibody to the Hodgkin's disease-associated antigen CD30 induces activation and long-term growth of human autoreactive gamma delta T cell clone. Cell Immunol 1994 0.77
106 Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol 2001 0.76
107 Differential proliferative responses in subsets of human CD28+ cells delineated by BB27 mAb. Int Immunol 1994 0.76
108 CD antigens 2001: aims and results of HLDA Workshops. Stem Cells 2001 0.76
109 CD antigens 2001. Tissue Antigens 2001 0.76
110 Involvement of IFNbeta on IFNgamma and nitric oxide (NO) production by bone marrow (BM) cells in response to lipopolysaccharide. Biomed Pharmacother 2006 0.76
111 [Anomalies of the immune system in chronic inflammatory bowel diseases]. Gastroenterol Clin Biol 1994 0.75
112 Detection of T cell receptor alpha chain locus rearrangements in human antigen-specific T lymphocyte clones using a DNA probe specific for chromosome region 14q11. J Exp Med 1986 0.75
113 Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in paroxysmal nocturnal hemoglobinuria. Curr Mol Med 2012 0.75
114 [Mode of action of a soluble restricted factor, a suppressor of the allogeneic proliferative response in man]. C R Seances Acad Sci D 1980 0.75
115 [Contribution of immunotherapy to the treatment of T-cell lymphoma of the skin]. Presse Med 1999 0.75
116 [The antigen receptor on the T-lymphocyte: from molecular biology to therapeutic implications]. Presse Med 1987 0.75
117 Clonal analysis of B cell growth and differentiation activities induced from T lymphocytes upon triggering of T3-Ti and T11 pathways. J Immunol 1987 0.75
118 Human cells allosensitized in vitro release soluble suppressor factors: presence of at least two distinct factors. Ann Inst Pasteur Immunol 1985 0.75
119 Functional role of CD101 on skin dendritic cells. Adv Exp Med Biol 1997 0.75
120 Identification and analysis of the human CD160 promoter: implication of a potential AML-1 binding site in promoter activation. Genes Immun 2009 0.75
121 Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma. Br J Dermatol 2003 0.75
122 Interleukin-13 responsiveness and interleukin-13 receptor expression in non-Hodgkin's lymphoma and reactive lymph node B cells. Modulation by CD40 activation. Eur Cytokine Netw 1997 0.75
123 CD antigens 2001. Int Immunol 2001 0.75
124 In vitro allostimulation of peripheral blood mononuclear cells generates autologous reactive T lymphocytes: analysis at the clonal level. Hum Immunol 1986 0.75
125 [New developments in Sézary syndrome]. Ann Dermatol Venereol 2011 0.75
126 CD antigens 2001. Eur J Immunol 2001 0.75
127 CD antigens 2001. Immunology 2001 0.75
128 No modulation of circulating natural killer cell and natural killer receptor bearing memory T cell subsets in patients with atopic dermatitis. J Invest Dermatol 2000 0.75
129 Enhanced CD3 monoclonal antibody induced proliferation of colonic mucosal T lymphocytes in Crohn's disease patients free of corticosteroid or immunosuppressor treatment. Clin Immunol Immunopathol 1996 0.75
130 Regulation of the human allogeneic proliferative response in vitro. Immunogenetics 1981 0.75
131 Human T lymphocyte clones with killer or natural killer activity. J Immunol Methods 1986 0.75
132 [Immunotherapy of malignant melanoma]. Pathol Biol (Paris) 1990 0.75
133 G10.3 monoclonal antibody identifies novel functional cell surface structures expressed by normal B lymphocytes and various malignant cell lines. Tissue Antigens 1999 0.75
134 CD antigens 2001. Cell Immunol 2001 0.75
135 The receptors regulating natural cytotoxic effector functions. Arch Immunol Ther Exp (Warsz) 2001 0.75
136 Production and characterization of 22 monoclonal antibodies directed against S 20499, a new potent 5-HT1A chiral agonist: influence of the hapten structure on specificity and stereorecognition. Pharm Res 1999 0.75
137 Modulation of allogenic reaction by ticlopidine treatment. Int J Immunopharmacol 1991 0.75
138 Delineation of human cord blood hematopoietic progenitor cell subsets with a unique monoclonal antibody AY19. Tissue Antigens 1998 0.75
139 Differential reactivity of human lymphocytes allosensitized in vitro in hormonally defined medium or medium supplemented with plasma. Cell Immunol 1983 0.75
140 Immunoactive products of human placenta. II. Direct inhibition of non-MHC restricted cytolytic activity of human CD3 alpha-beta but not CD3 gamma-delta expressing T cell clones. J Reprod Immunol 1989 0.75
141 Biochemical purification of various receptor molecules involved in human T lymphocyte activation. Separation of 9.3 antigen from the T cell receptor for antigen. Scand J Immunol 1988 0.75
142 Utilization of two different T cell receptors by T cell acute lymphoblastic lymphoma and leukemia. Nouv Rev Fr Hematol 1990 0.75
143 [T lymphocyte receptors after allogenic bone marrow transplantation]. Nouv Rev Fr Hematol 1988 0.75
144 CD4+ CD56+ blastic tumor cells express CD101 molecules. J Invest Dermatol 2005 0.75
145 Detection of a T cell receptor delta chain with an anti-TCR alpha chain serum. Clin Immunol Immunopathol 1990 0.75
146 Identification of a novel functional 85-kD glycoprotein restricted to long-term dividing human lymphocytic lines. Hum Immunol 1993 0.75
147 [Suppressor cells and factor of the allogeneic proliferative response in man]. C R Seances Soc Biol Fil 1980 0.75
148 Lack of permissivity of human monoclonal CD4+ lymphocytes to HIV. Cancer Detect Prev 1990 0.75
149 MHC class II gene products specific autoreactive T cell clones provide inducer as well as amplifier function for B cell Ig production. Behring Inst Mitt 1985 0.75